US Patent Litigations are now available. Check here

Explore Birdie Biopharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 26, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3166976Feb 23, 2022Anti-Pd-L1 Combinations For Treating Tumors1